Summary

The global body contouring treatments market is expected to reach USD 2.58 billion by 2029 from USD 1.46 billion in 2024, at a CAGR of 10.0% from 2024 to 2029. Increase in acceptance of aesthetic procedures, coupled with personalized and flexible financing plans has increased the demand for these products. Growing interest in anti-aging procedures are more prevalent in aging population. Body contouring procedures helps to reshape and improvesconfidence. Moreover,increased benefits of minimally invasive and non-invasive body contouring procedures have driven demand for body contouring treatments market.

“The non-invasive technologies segment of technology segment held the largest share of the market in 2023”
The body contouring treatments market is segmented based on technology into invasive technologies and non-invasive technologies. The non-invasive technologies accounted for a major share in 2023. Increase in technological innovations, rise in advertisement, and the rising adoption of devices due to less incisions is anticipated to fuel the growth of the segment. Treatments for non-invasive body contouring that involve radiofrequency, ultrasound, cryolipolysis (freezing fat), and laser-based techniques have significantly improved in tems of safety and effectiveness. These technologies have a wide range of benefits, which contribute to the non-invasive treatment popularity among individuals.

“The non-surgical fat reduction segment of application segment held the largest share of the market in 2023”
The body contouring treatments market can be segmented based on application into abdominoplasty, liposuction, non-invasive fat reduction, cellulite treatment, and other applications. Increasing number of beauty centers and rising adoption mainly due to improved accuracy and better outcomes drives the market. The non-surgical fat reduction treatments are gaining popularity across all patient types and ages. Hence, broader acceptance for treatment procedures due to innovative technologies supports the surge in demand that further drives the growth for the non-surgical fat reduction segment.

“The female patients segment for patient type segment to hold the largest market share in 2023”.
Based on patient type , the body contouring treatments market is segmented into female patients and male patients. Female patients is the major segment, accounting for the largest body contouring treatments market share in 2023. The increase in awareness about non-invasive body contouring procedures, rise in post-pregnancy body reconstruction procedures, increase in influencer endorsements, and social media promotion supports the growth of the segment.

“The aesthetic clinics segment for the end user segment is projected to register a significant CAGR during the forecast period.”
The body contouring treatments market is segmented by end-users into hospitals, aesthetic clinics, and medical spas & beauty centers. The hospitals accounted for a major end-user market share in 2023. The increase in spending on body shaping procedures and rise in medical tourism, and rising disposable income per capita is anticipated to propel the segment growth. Furthermore, rising adoption of new and improved devices in the hopsitals is expected to support the growth of this segment.

“The market in the Asia Pacific region is expected to witness the highest growth during the forecast period.”
The north america region accounted for major share in 2023. Asia pacific region to grow at the highest CAGR in body contouring treatments market. Healthcare infrastructure and service investments, especially in the emerging economies, are fostering the development of medical aesthetics, which leads to growing demand for body contouring. In this regard, market leaders have increased their efforts to strengthen their presence in the Asia Pacific market to meet the ever-growing requirement for body contouring treatment. The availability and accessibility of the service in this market have also been enhanced by the increasing presence of aesthetic clinics, particularly in the APAC region.

A breakdown of the primary participants referred to for this report is provided below:
• By Company Type: Tier 1–30%, Tier 2–42%, and Tier 3– 28%
• By Designation: Director-level–10%, C-level–14%, and Others–76%
• By Region: North America–40%, Europe–30%, Asia Pacific–22%, Latin America–6%, and RoW- 10%
The prominent players in the body contouring treatments market are as AbbVie Inc. (US), InMode Ltd. (Israel), Bausch Health Companies Inc. (Canada), Cynosure Lutronic (US), Venus Concept (Canada), EL.EN.S.P.A (Italy), Sisram Medical Ltd. (Israel), BTL Industries(UK), Sharplight Technologies Inc. (Canada), Sciton Inc. (US), Candela Corporation (US), Fotona (Solvenia )
The study includes as in-depth competitive analysis of these key players in the authentication and brand protection market, with their company profiles recent developments,and key market stratergies

Research Coverage

This report studies the body contouring treatments market based on technology, application, patient type, end user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will help market leaders and new entrants with information on the closest approximations of the revenue numbers for the overall body contouring treatments market and the subsegments. It will also help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.

This report provides insights on the following pointers:
• Analysis of key drivers (Growing adoption for minimally invasive and non-invasive body contouring procedure, increasing demand for aesthetic treatments among men, rising adoption of new and innovative body contouring technologies , broad acceptance of aesthetic procedure and growing attention on appearance and body image), restraints (high cost of treatment and inadequate reimbursement policies), opportunities (growth potential in emerging economies), and challenges (social and cultural barrriers in emerging economies, stringent regulatory compliance and safety standards) influencing the growth of the body contouring treatments market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the body contouring treatments market
• Market Development: Comprehensive information about lucrative markets–the report analyses the body contouring treatments market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the body contouring treatments market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players, such as AbbVie Inc. (US), Inmode Ltd. (Israel), Bausch Health Companies Inc. (Canada), Cynosure Lutronic (US), Sisram Medical Ltd (Israel)

ページTOPに戻る

Table of Contents

1 INTRODUCTION 26
1.1 STUDY OBJECTIVES 26
1.2 MARKET DEFINITION 26
1.3 INCLUSIONS AND EXCLUSIONS 27
1.4 STUDY SCOPE 28
1.4.1 MARKETS COVERED 28
1.4.2 YEARS CONSIDERED 29
1.4.3 CURRENCY CONSIDERED 29
1.5 STAKEHOLDERS 29
1.6 IMPACT OF AI/GEN AI 29
2 RESEARCH METHODOLOGY 30
2.1 RESEARCH DATA 30
2.1.1 SECONDARY DATA 30
2.1.1.1 Key sources for secondary research 30
2.1.2 PRIMARY DATA 31
2.1.2.1 Key primary sources 32
2.1.2.2 Key industry insights 33
2.1.2.3 Breakdown of primary interviews 33
2.2 MARKET SIZE ESTIMATION 34
2.2.1 BOTTOM-UP APPROACH 35
2.2.1.1 Company revenue estimation approach 36
2.2.1.2 Customer-based market estimation 37
2.2.1.3 Growth forecast approach 38
2.2.1.4 CAGR projections 38
2.3 DATA TRIANGULATION 38
2.4 MARKET SHARE ANALYSIS 39
2.5 RESEARCH ASSUMPTIONS 40
2.5.1 PARAMETRIC ASSUMPTIONS 40
2.5.2 GROWTH RATE ASSUMPTIONS 40
2.6 RESEARCH LIMITATIONS 41
2.7 RISK ASSESSMENT 41
3 EXECUTIVE SUMMARY 42
4 PREMIUM INSIGHTS 46
4.1 BODY CONTOURING TREATMENTS MARKET OVERVIEW 46
4.2 NORTH AMERICA: BODY CONTOURING TREATMENTS MARKET, BY TECHNOLOGY 47
4.3 ASIA PACIFIC: BODY CONTOURING TREATMENTS MARKET, BY END USER 47
4.4 EUROPE: BODY CONTOURING TREATMENTS MARKET, BY APPLICATION 48
4.5 GEOGRAPHIC SNAPSHOT OF BODY CONTOURING TREATMENTS MARKET 49
5 MARKET OVERVIEW 50
5.1 INTRODUCTION 50
5.2 MARKET DYNAMICS 50
5.2.1 DRIVERS 51
5.2.1.1 Growing adoption of minimally invasive and non-invasive body contouring procedures 51
5.2.1.2 Increasing demand for aesthetic treatments among men 52
5.2.1.3 Rising adoption of new and innovative body contouring technologies 53
5.2.1.4 Widespread social media influence and cultural changes 55
5.2.2 RESTRAINTS 56
5.2.2.1 High cost of treatment and inadequate reimbursement policies 56
5.2.3 OPPORTUNITIES 56
5.2.3.1 Growth potential in emerging economies 56
5.2.4 CHALLENGES 59
5.2.4.1 Social and cultural barriers 59
5.2.4.2 Stringent regulatory compliance and safety standards 59
5.3 VALUE CHAIN ANALYSIS 60
5.3.1 RESEARCH & PRODUCT DEVELOPMENT 61
5.3.2 RAW MATERIAL PROCUREMENT AND MANUFACTURING 61
5.3.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES 61
5.4 SUPPLY CHAIN ANALYSIS 62
5.4.1 MANUFACTURERS 62
5.4.1.1 Prominent companies 62
5.4.1.2 Small and medium-sized enterprises 62
5.4.2 END USERS 62
5.5 ECOSYSTEM ANALYSIS 63
5.6 REGULATORY ANALYSIS 64
5.6.1 REGULATORY LANDSCAPE 64
5.6.1.1 North America 64
5.6.1.1.1 US 64
5.6.1.1.2 Canada 67
5.6.1.2 Europe 68
5.6.1.3 Asia Pacific 71
5.6.1.3.1 Japan 71
5.6.1.3.2 China 71
5.6.1.3.3 India 73
5.6.1.4 Latin America 73
5.6.1.4.1 Brazil 73

5.6.2 REGULATORY APPROVALS 74
5.6.3 KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 74
5.7 REIMBURSEMENT SCENARIO ANALYSIS 77
5.8 INVESTMENT AND FUNDING SCENARIO 78
5.9 PRICING ANALYSIS 79
5.9.1 AVERAGE SELLING PRICE OF KEY PLAYERS, BY TECHNOLOGY 80
5.9.2 AVERAGE SELLING PRICE OF BODY CONTOURING DEVICES, BY REGION 81
5.10 TRADE ANALYSIS 82
5.10.1 IMPORT DATA 83
5.10.2 EXPORT DATA 84
5.11 PATENT ANALYSIS 85
5.12 PORTER’S FIVE FORCES ANALYSIS 87
5.12.1 THREAT OF NEW ENTRANTS 88
5.12.2 THREAT OF SUBSTITUTES 88
5.12.3 BARGAINING POWER OF SUPPLIERS 88
5.12.4 BARGAINING POWER OF BUYERS 88
5.12.5 INTENSITY OF COMPETITIVE RIVALRY 88
5.13 KEY STAKEHOLDERS AND BUYING CRITERIA 89
5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 89
5.13.2 KEY BUYING CRITERIA 90
5.14 KEY CONFERENCES AND EVENTS, 2025–2026 91
5.15 CASE STUDY ANALYSIS 93
5.15.1 IMPROVED FAT REDUCTION PROCEDURES USING LARGER APPLICATOR 93
5.15.2 ENHANCED SUPPLY CHAIN AND OPERATIONAL EFFICIENCY WITH HIGHER RESEARCH & DEVELOPMENT 93
5.16 TECHNOLOGY ANALYSIS 94
5.16.1 KEY TECHNOLOGIES 94
5.16.1.1 Thermal technologies 94
5.16.1.2 Non-thermal technologies 95
5.16.2 COMPLEMENTARY TECHNOLOGIES 95
5.16.2.1 Skin cooling systems 95
5.16.3 ADJACENT TECHNOLOGIES 95
5.16.3.1 Treatment planning software 95
5.17 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 96
5.18 UNMET NEEDS 97
5.19 IMPACT OF AI/GEN AI ON BODY CONTOURING TREATMENTS MARKET 98
5.19.1 KEY USE CASES 99

6 BODY CONTOURING TREATMENTS MARKET, BY TECHNOLOGY 100
6.1 INTRODUCTION 101
6.2 INVASIVE TECHNOLOGIES 101
6.2.1 INVASIVE RADIOFREQUENCY TECHNOLOGY 102
6.2.1.1 Growing inclination toward skin tightening to propel market 102
6.2.2 INVASIVE LASER TECHNOLOGY 103
6.2.2.1 Higher advantages compared to traditional techniques to speed up growth 103
6.2.3 INVASIVE ULTRASOUND TECHNOLOGY 104
6.2.3.1 Targeted fat reduction and minimal discomfort to augment growth 104
6.3 NON-INVASIVE TECHNOLOGIES 105
6.3.1 NON-INVASIVE RADIOFREQUENCY TECHNOLOGY 107
6.3.1.1 Rising use of cellulite treatment, fat reduction, and skin tightening to drive market 107
6.3.2 NON-INVASIVE LASER TECHNOLOGY 108
6.3.2.1 Growing adoption in hospitals and aesthetic clinics to fuel market 108
6.3.3 NON-INVASIVE ULTRASOUND TECHNOLOGY 108
6.3.3.1 Need for precise temperature management control to accelerate growth 108
6.3.4 CRYOLIPOLYSIS TECHNOLOGY 109
6.3.4.1 Low risk and minimal side effects to facilitate growth 109
6.3.5 OTHER NON-INVASIVE TECHNOLOGIES 110
7 BODY CONTOURING TREATMENTS MARKET, BY GENDER 112
7.1 INTRODUCTION 113
7.2 FEMALE PATIENTS 113
7.2.1 GROWING USE OF BODY CONTOURING TO ADDRESS POST-SURGICAL CHANGES TO BOOST MARKET 113
7.3 MALE PATIENTS 115
7.3.1 INCREASING SHIFT IN SOCIAL AND AESTHETIC STANDARDS TO EXPEDITE GROWTH 115
8 BODY CONTOURING TREATMENTS MARKET, BY APPLICATION 117
8.1 INTRODUCTION 118
8.2 NON-SURGICAL FAT REDUCTION 118
8.2.1 GROWING PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES TO FUEL MARKET 118
8.3 CELLULITE REDUCTION 120
8.3.1 RISING OBESITY RATES TO SUPPORT MARKET GROWTH 120
8.4 LIPOSUCTION 120
8.4.1 GROWING DEMAND FOR COSMETIC ENHANCEMENT WITH SHORTER RECOVERY TIMES TO DRIVE MARKET 120
8.5 ABDOMINOPLASTY 121
8.5.1 INCREASING DESIRE FOR AESTHETIC IMPROVEMENTS TO PROMOTE GROWTH 121
8.6 OTHER APPLICATIONS 122
9 BODY CONTOURING TREATMENTS MARKET, BY END USER 124
9.1 INTRODUCTION 125
9.2 HOSPITALS 125
9.2.1 BOOMING MEDICAL TOURISM TO CONTRIBUTE TO MARKET GROWTH 125
9.3 AESTHETIC CLINICS 126
9.3.1 GROWING ESTABLISHMENT OF SPECIALTY CLINICS TO DRIVE MARKET 126
9.4 MEDICAL SPAS & BEAUTY CENTERS 127
9.4.1 RISING FOCUS ON BODY APPEARANCE TO AID GROWTH 127
10 BODY CONTOURING TREATMENTS MARKET, BY REGION 129
10.1 INTRODUCTION 130
10.2 NORTH AMERICA 130
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 135
10.2.2 US 136
10.2.2.1 Growing public acceptance of body contouring procedures to drive market 136
10.2.3 CANADA 138
10.2.3.1 Rising inclination toward reducing signs of aging to aid growth 138
10.3 EUROPE 140
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 144
10.3.2 GERMANY 145
10.3.2.1 Increasing volume of aesthetic procedures to drive market 145
10.3.3 FRANCE 147
10.3.3.1 Increasing demand for age-related aesthetic treatments to spur growth 147
10.3.4 UK 149
10.3.4.1 Rising focus of men on body aesthetics to encourage growth 149
10.3.5 ITALY 151
10.3.5.1 Gowing adoption of surgical procedures among young females to boost market 151
10.3.6 SPAIN 153
10.3.6.1 Growing availability of high-quality and effective products to fuel market 153
10.3.7 REST OF EUROPE 155
10.4 ASIA PACIFIC 157
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 161
10.4.2 JAPAN 162
10.4.2.1 Presence of medical aesthetic associations to spur growth 162
10.4.3 CHINA 165
10.4.3.1 Increased availability of cosmetic surgery apps and online services to support growth 165

10.4.4 INDIA 167
10.4.4.1 Increasing disposable income to contribute to market growth 167
10.4.5 AUSTRALIA 169
10.4.5.1 Favorable government initiatives to promote growth 169
10.4.6 SOUTH KOREA 171
10.4.6.1 Rising influx of foreign patients to facilitate growth 171
10.4.7 REST OF ASIA PACIFIC 173
10.5 LATIN AMERICA 175
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 178
10.5.2 BRAZIL 179
10.5.2.1 Heightened awareness regarding body contouring enhancements to stimulate growth 179
10.5.3 MEXICO 181
10.5.3.1 Increase in patient inflow from US to sustain growth 181
10.5.4 REST OF LATIN AMERICA 183
10.6 MIDDLE EAST & AFRICA 185
10.6.1 GROWING AVAILABILITY OF HIGH-QUALITY TREATMENTS TO DRIVE MARKET 185
10.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 189
11 COMPETITIVE LANDSCAPE 191
11.1 OVERVIEW 191
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 191
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN BODY CONTOURING TREATMENTS MARKET 191
11.3 REVENUE ANALYSIS, 2019−2023 194
11.4 MARKET SHARE ANALYSIS, 2023 195
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 197
11.5.1 STARS 197
11.5.2 EMERGING LEADERS 197
11.5.3 PERVASIVE PLAYERS 197
11.5.4 PARTICIPANTS 197
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 199
11.5.5.1 Company footprint 199
11.5.5.2 Technology footprint 200
11.5.5.3 Gender footprint 201
11.5.5.4 Application footprint 202
11.5.5.5 End-user footprint 203
11.5.5.6 Region footprint 204
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 205
11.6.1 PROGRESSIVE COMPANIES 205
11.6.2 RESPONSIVE COMPANIES 205
11.6.3 DYNAMIC COMPANIES 205
11.6.4 STARTING BLOCKS 205
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 207
11.7 COMPANY VALUATION AND FINANCIAL METRICS 209
11.7.1 COMPANY VALUATION 209
11.7.2 FINANCIAL METRICS 209
11.8 BRAND/PRODUCT COMPARISON 210
11.9 COMPETITIVE SCENARIO 210
11.9.1 PRODUCT LAUNCHES AND APPROVALS 210
11.9.2 DEALS 213
11.9.3 EXPANSIONS 214
12 COMPANY PROFILES 215
12.1 KEY PLAYERS 215
12.1.1 ABBVIE INC. 215
12.1.1.1 Business overview 215
12.1.1.2 Products offered 216
12.1.1.3 Recent developments 217
12.1.1.3.1 Product launches and approvals 217
12.1.1.4 MnM view 217
12.1.1.4.1 Key strengths 217
12.1.1.4.2 Strategic choices 217
12.1.1.4.3 Weaknesses and competitive threats 217
12.1.2 INMODE LTD. 218
12.1.2.1 Business overview 218
12.1.2.2 Products offered 219
12.1.2.3 Recent developments 220
12.1.2.3.1 Product launches and approvals 220
12.1.2.3.2 Deals 221
12.1.2.4 MnM view 221
12.1.2.4.1 Key strengths 221
12.1.2.4.2 Strategic choices 221
12.1.2.4.3 Weaknesses and competitive threats 221
12.1.3 BAUSCH HEALTH COMPANIES INC. 222
12.1.3.1 Business overview 222
12.1.3.2 Products offered 223
12.1.3.3 Recent developments 224
12.1.3.3.1 Product launches and approvals 224
12.1.3.4 MnM view 224
12.1.3.4.1 Key strengths 224
12.1.3.4.2 Strategic choices 224
12.1.3.4.3 Weaknesses and competitive threats 224

12.1.4 CYNOSURE LUTRONIC 225
12.1.4.1 Business overview 225
12.1.4.2 Products offered 225
12.1.4.3 Recent developments 226
12.1.4.3.1 Deals 226
12.1.4.4 MnM view 226
12.1.4.4.1 Key strengths 226
12.1.4.4.2 Strategic choices 226
12.1.4.4.3 Weaknesses and competitive threats 226
12.1.5 SISRAM MEDICAL LTD 227
12.1.5.1 Business overview 227
12.1.5.2 Products offered 228
12.1.5.3 Recent developments 229
12.1.5.3.1 Product launches and approvals 229
12.1.5.3.2 Deals 229
12.1.5.3.3 Expansions 230
12.1.5.4 MnM view 230
12.1.5.4.1 Key strengths 230
12.1.5.4.2 Strategic choices 230
12.1.5.4.3 Weaknesses and competitive threats 230
12.1.6 CUTERA, INC. 231
12.1.6.1 Business overview 231
12.1.6.2 Products offered 232
12.1.6.3 Recent developments 233
12.1.6.3.1 Product launches and approvals 233
12.1.7 EL.EN. S.P.A. 234
12.1.7.1 Business overview 234
12.1.7.2 Products offered 235
12.1.7.2.1 Product launches and approvals 236
12.1.8 VENUS CONCEPT 237
12.1.8.1 Business overview 237
12.1.8.2 Products offered 238
12.1.8.3 Recent developments 239
12.1.8.3.1 Product launches and approvals 239
12.1.8.3.2 Deals 240
12.1.9 SHARPLIGHT TECHNOLOGIES INC. 241
12.1.9.1 Business overview 241
12.1.9.2 Products offered 241
12.1.9.3 Recent developments 242
12.1.9.3.1 Product launches and approvals 242

12.1.10 SCITON 243
12.1.10.1 Business overview 243
12.1.10.2 Products offered 243
12.1.10.3 Recent developments 243
12.1.10.3.1 Product launches and approvals 243
12.1.11 CANDELA CORPORATION 244
12.1.11.1 Business overview 244
12.1.11.2 Products offered 244
12.1.11.3 Recent developments 244
12.1.11.3.1 Deals 244
12.1.12 BTL INDUSTRIES 245
12.1.12.1 Business overview 245
12.1.12.2 Products offered 245
12.1.12.3 Recent developments 246
12.1.12.3.1 Product launches and approvals 246
12.1.12.3.2 Deals 246
12.1.13 FOTONA 247
12.1.13.1 Business overview 247
12.1.13.2 Products offered 247
12.1.13.3 Recent developments 248
12.1.13.3.1 Product launches and approvals 248
12.1.14 GZ MTS ELECTRONICS CO., LTD. 249
12.1.14.1 Business overview 249
12.1.14.2 Products offered 249
12.1.15 ROHRER AESTHETICS, INC. 252
12.1.15.1 Business overview 252
12.1.15.2 Products offered 252
12.1.15.3 Recent developments 253
12.1.15.3.1 Product launches and approvals 253
12.1.15.3.2 Deals 253
12.2 OTHER PLAYERS 254
12.2.1 GBS INTERNATIONAL HOLDING LTD. 254
12.2.2 SINCLAIR 255
12.2.3 THERMI 256
12.2.4 YOLO MEDICAL INC. 256
12.2.5 DOMINION AESTHETIC TECHNOLOGIES, INC. 257
12.2.6 ZIMMER MEDIZIN SYSTEME GMBH 258
12.2.7 ERCHONIA CORPORATION 259
12.2.8 CLASSYS INC. 260
12.2.9 WON TECH CO., LTD. 261
12.2.10 CELLSOUND AESTHETICS 262
13 APPENDIX 263
13.1 DISCUSSION GUIDE 263
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 267
13.3 CUSTOMIZATION OPTIONS 269
13.4 RELATED REPORTS 269
13.5 AUTHOR DETAILS 270